These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7328769)

  • 21. [Histopathology and clinical course of chronic, myeloproliferative diseases].
    Georgii A
    Verh Dtsch Ges Pathol; 1983; 67():214-34. PubMed ID: 6666265
    [No Abstract]   [Full Text] [Related]  

  • 22. [Isolation of size-dependent human platelet subpopulations. I. The method for isolation of size-dependent platelet subpopulations by counterflow centrifugal elutriation].
    Saigo K; Ryo R; Nakaya Y; Yamaguchi N; Ryo R; Saigo K; Ueda K
    Rinsho Byori; 1986 Oct; 34(10):1159-62. PubMed ID: 3807001
    [No Abstract]   [Full Text] [Related]  

  • 23. The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
    Dapling RB; Snowden JA; West J; Talbot JF; Nelson ME; Greaves M
    Clin Lab Haematol; 1996 Dec; 18(4):277-9. PubMed ID: 9054702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of hemopoietic dysplasia accompanied with various prodromal symptoms (author's transl)].
    Katsuki A; Kayawake S; Yoneda S; Hamami T; Nakata T; Nishio A; Hosoda M; Haruyama H; Sugishima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1979 Dec; 20(12):1655-61. PubMed ID: 541851
    [No Abstract]   [Full Text] [Related]  

  • 26. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
    Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
    Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rate of megathrombocytes in different haemopathies. Preliminary clinical appraisal (author's transl)].
    Gómez García P; Giralt M; Raichs A
    Sangre (Barc); 1974; 19(3):259-67. PubMed ID: 4439123
    [No Abstract]   [Full Text] [Related]  

  • 29. [Limits of platelet aggregation tests for investigating thromboses (author's transl)].
    Sie P; Cousin F; Barret A; Caranobe C; Boneu B; Bierme R
    Nouv Presse Med; 1980 Oct; 9(36):2629-32. PubMed ID: 7433051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease.
    Salem HH; van der Weyden MB; Koutts J; Firkin BG
    JAMA; 1980 Sep; 244(10):1122-3. PubMed ID: 7411766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical course and terminal features of chronic myeloproliferative syndrome].
    Yonemitsu H
    Rinsho Ketsueki; 1988 Jul; 29(7):950-9. PubMed ID: 3184481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adhesiveness and aggregation (author's transl)].
    Deguchi K; Ueno H
    Rinsho Byori; 1981 Apr; 29(4):335-43. PubMed ID: 7321219
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet function and thromboxane synthesis in myeloproliferative disorders.
    Zahavi M; Zahavi J
    Blood; 1993 Aug; 82(4):1377-8. PubMed ID: 8353296
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Philadelphia chromosome-negative chronic myeloproliferative disease.
    Thiele J
    Am J Clin Pathol; 2009 Aug; 132(2):261-80. PubMed ID: 19605821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases.
    Alonci A; Allegra A; Bellomo G; Penna G; D'Angelo A; Quartarone E; Musolino C
    Hematol Oncol; 2008 Dec; 26(4):235-9. PubMed ID: 18504767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function.
    Boughton BJ; Corbett WE; Ginsburg AD
    J Clin Pathol; 1977 Mar; 30(3):228-34. PubMed ID: 845271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor IX activation peptide and soluble selectins in patients with chronic myeloproliferative disorders.
    Cella G; Randi ML; Sbarai A; Bauer KA; Barzega S; Rosenberg RD
    Haematologica; 2002 Jun; 87(6):671-2. PubMed ID: 12031932
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myeloproliferative disorders (author's transl)].
    Rousso C
    Schweiz Rundsch Med Prax; 1974 Nov; 63(45):1335-7. PubMed ID: 4438251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.